Abstract
Relevance: Breast cancer (BC) is the leading cause of female cancer mortality worldwide. The constant development of treatment strategies
 and diagnostic tools has increased the survival rate for BC. Next-generation genome sequencing (NGS) identifies the genetic changes responsible
 for tumor emergence, development, and metastasis. NGS has expanded the capacities of BC diagnostics, treatment, and early prevention in women.
 The study aimed to identify breast cancer risk factors in women.
 Methods: Publications were obtained from the following databases: PubMed, Google Scholar, and eLibrary. The depth of the search was 5 to
 10 years. As a result, 100 literary sources were identified, of which 26 publications formed the scientific material for this review.
 Results: Breast cancer is a heterogeneous disease driven by genetic abnormalities and epigenetic alterations.
 Conclusion: Gene mutations do not change. Genetic testing shall be introduced and used as a preventive measure to reduce BC incidence.
 Lifestyle-related BC risk factors can be modified to reduce BC risk.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
